Literature DB >> 10933394

CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification.

M Fujimoto1, Y Fujimoto, J C Poe, P J Jansen, C A Lowell, A L DeFranco, T F Tedder.   

Abstract

CD19 regulates constitutive and antigen receptor-induced signaling thresholds in B lymphocytes through its unique cytoplasmic domain. Herein, we demonstrate a novel molecular mechanism where interactions between CD19 and Lyn amplify basal and antigen receptor-induced Src family kinase activation. Lyn expression was required for CD19 tyrosine phosphorylation in primary B cells. Experiments with purified proteins demonstrated that CD19-Y513 was Lyn's initial phosphorylation and binding site. This led to processive phosphorylation of CD19-Y482, which recruited a second Lyn molecule, allowing for transphosphorylation and amplification of Lyn activation. In vivo, CD19 deficiency impaired, and CD19 overexpression enhanced, Lyn kinase activity. Thus, CD19 functions as a specialized adapter protein for the amplification of Src family kinases that is crucial for intrinsic and antigen receptor-induced signal transduction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10933394     DOI: 10.1016/s1074-7613(00)00007-8

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  56 in total

Review 1.  Role of CD19 signal transduction in B cell biology.

Authors:  Robert H Carter; Yue Wang; Stephen Brooks
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  Molecular underpinning of B-cell anergy.

Authors:  Yuval Yarkoni; Andrew Getahun; John C Cambier
Journal:  Immunol Rev       Date:  2010-09       Impact factor: 12.988

3.  CD19 controls Toll-like receptor 9 responses in human B cells.

Authors:  Henner Morbach; Jean-Nicolas Schickel; Charlotte Cunningham-Rundles; Mary Ellen Conley; Ismail Reisli; Jose Luis Franco; Eric Meffre
Journal:  J Allergy Clin Immunol       Date:  2015-10-21       Impact factor: 10.793

Review 4.  The conundrum of inhibitory signaling by ITAM-containing immunoreceptors: potential molecular mechanisms.

Authors:  Paul M Waterman; John C Cambier
Journal:  FEBS Lett       Date:  2010-09-28       Impact factor: 4.124

5.  CD19 expression in B cells is important for suppression of contact hypersensitivity.

Authors:  Rei Watanabe; Manabu Fujimoto; Nobuko Ishiura; Yoshihiro Kuwano; Hiroko Nakashima; Norihito Yazawa; Hitoshi Okochi; Shinichi Sato; Thomas F Tedder; Kunihiko Tamaki
Journal:  Am J Pathol       Date:  2007-06-07       Impact factor: 4.307

Review 6.  Germinal center structure and function: lessons from CD19.

Authors:  Robert H Carter; Riley Myers
Journal:  Semin Immunol       Date:  2008-02-19       Impact factor: 11.130

7.  Anti-CD19 and anti-CD22 monoclonal antibodies increase the effectiveness of chemotherapy in Pre-B acute lymphoblastic leukemia cell lines.

Authors:  C Stanciu-Herrera; C Morgan; L Herrera
Journal:  Leuk Res       Date:  2007-08-15       Impact factor: 3.156

8.  The transmembrane tyrosine of micro-heavy chain is required for BCR destabilization and entry of antigen into clathrin-coated vesicles.

Authors:  Jin Hyang Kim; Jennifer A Rutan; Barbara J Vilen
Journal:  Int Immunol       Date:  2007-11-01       Impact factor: 4.823

9.  Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1.

Authors:  Chuanlin Ding; Li Wang; Jose Marroquin; Jun Yan
Journal:  Blood       Date:  2008-07-31       Impact factor: 22.113

10.  Autoimmunity risk alleles: hotspots in B cell regulatory signaling pathways.

Authors:  John C Cambier
Journal:  J Clin Invest       Date:  2013-04-24       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.